Value of Plasma NGAL in the Diagnosis of Cardiorenal Syndrome Type 1-Reference-Cited by-同舟云学术

Value of Plasma NGAL in the Diagnosis of Cardiorenal Syndrome Type 1

Published:2020-10-21 Issue:1 Volume:18 Page:em268
ISSN:2516-3507
Container-title:Electronic Journal of General Medicine
language:
Short-container-title:Electron J Gen Med

Author:

Phan Hao Thai,Hoang Tien Anh,Hoang Bao Bui,Huynh Minh Van

Publisher

Modestum Publishing Ltd

Subject

General Medicine

Link

https://www.ejgm.co.uk/download/value-of-plasma-ngal-in-the-diagnosis-of-cardiorenal-syndrome-type-1-8953.pdf

Reference16 articles.

1. Prins KW, Thenappan T, Markowitz JS, et al. Cardiorenal syndrome type 1: Renal Dysfunction in Acute Decompensated Heart Failure. J Clin Outcomes Manag, 2015;22(10):443-54. PMCID:PMC4855293

2. Lassus JPE, Nieminen MS, Peuhkurinen K, et al. Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. Eur Heart J., 2010;31:2791-8. https://doi.org/10.1093/eurheartj/ehq293 PMid:20801926

3. Nakada Y, Kawakami R, Matsui M, et al. Prognostic Value of Urinary Neutrophil Gelatinase-Associated Lipocalin on the First Day of Admission for Adverse Events in Patients with Acute Decompensated Heart Failure. J Am Heart Assoc., 2017;6:e004582. https://doi.org/10.1161/JAHA.116.004582 PMid:28522674 PMCid:PMC5524060

4. Ezekowitz JA, O’Meara E, McDonald MA, et al. 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Canadian Journal of Cardiology, 2017;33(11):1342-433. https://doi.org/10.1016/j.cjca.2017.08.022 PMid:29111106

5. Kellum JA, Lameire N, Aspelin P, et al. KDIGO clinical practice guideline for acute kidney injury. Kidney Int, 2012;2(1):138. https://doi.org/10.1038/kisup.2012.1